Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors
(2014) In Journal of Medicinal Chemistry 57(6). p.12-2807- Abstract
Searching for selective tankyrases (TNKSs) inhibitors, a new small series of 6,8-disubstituted triazolo[4,3-b]piridazines has been synthesized and characterized biologically. Structure-based optimization of the starting hit compound NNL (3) prompted us to the discovery of 4-(2-(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-ylamino)ethyl)phenol (12), a low nanomolar selective TNKSs inhibitor working as NAD isostere as ascertained by crystallographic analysis. Preliminary biological data candidate this new class of derivatives as a powerful pharmacological tools in the unraveling of TNKS implications in physiopathological conditions.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/e19496e7-2ca5-4226-bbc6-803c7fc93977
- author
- publishing date
- 2014-03-27
- type
- Contribution to journal
- publication status
- published
- keywords
- Adenosine Diphosphate Ribose/metabolism, Chromatography, High Pressure Liquid, Crystallography, X-Ray, Drug Design, Enzyme Inhibitors/chemical synthesis, Humans, Indicators and Reagents, Luciferases/genetics, Mass Spectrometry, Models, Molecular, Molecular Conformation, Pyridazines/chemical synthesis, Recombinant Proteins/drug effects, Structure-Activity Relationship, Tankyrases/antagonists & inhibitors, Triazoles/chemical synthesis
- in
- Journal of Medicinal Chemistry
- volume
- 57
- issue
- 6
- pages
- 6 pages
- publisher
- The American Chemical Society (ACS)
- external identifiers
-
- scopus:84897418380
- pmid:24527792
- ISSN
- 1520-4804
- DOI
- 10.1021/jm401356t
- language
- English
- LU publication?
- no
- id
- e19496e7-2ca5-4226-bbc6-803c7fc93977
- date added to LUP
- 2024-11-21 17:55:30
- date last changed
- 2025-07-05 12:26:59
@article{e19496e7-2ca5-4226-bbc6-803c7fc93977, abstract = {{<p>Searching for selective tankyrases (TNKSs) inhibitors, a new small series of 6,8-disubstituted triazolo[4,3-b]piridazines has been synthesized and characterized biologically. Structure-based optimization of the starting hit compound NNL (3) prompted us to the discovery of 4-(2-(6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-ylamino)ethyl)phenol (12), a low nanomolar selective TNKSs inhibitor working as NAD isostere as ascertained by crystallographic analysis. Preliminary biological data candidate this new class of derivatives as a powerful pharmacological tools in the unraveling of TNKS implications in physiopathological conditions.</p>}}, author = {{Liscio, Paride and Carotti, Andrea and Asciutti, Stefania and Karlberg, Tobias and Bellocchi, Daniele and Llacuna, Laura and Macchiarulo, Antonio and Aaronson, Stuart A and Schüler, Herwig and Pellicciari, Roberto and Camaioni, Emidio}}, issn = {{1520-4804}}, keywords = {{Adenosine Diphosphate Ribose/metabolism; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors/chemical synthesis; Humans; Indicators and Reagents; Luciferases/genetics; Mass Spectrometry; Models, Molecular; Molecular Conformation; Pyridazines/chemical synthesis; Recombinant Proteins/drug effects; Structure-Activity Relationship; Tankyrases/antagonists & inhibitors; Triazoles/chemical synthesis}}, language = {{eng}}, month = {{03}}, number = {{6}}, pages = {{12--2807}}, publisher = {{The American Chemical Society (ACS)}}, series = {{Journal of Medicinal Chemistry}}, title = {{Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-<i>b</i>]pyridazin-8-amine derivatives as tankyrase inhibitors}}, url = {{http://dx.doi.org/10.1021/jm401356t}}, doi = {{10.1021/jm401356t}}, volume = {{57}}, year = {{2014}}, }